Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Glaxo Wellcome synthesizes protein-binding agents

June 21, 1996

Thiophenolic compounds revealed by Searle

June 21, 1996

Asahi Brewery discloses antioxidants

June 21, 1996

Schering AG claims AMPA antagonists for neurodegenerative disorders

June 21, 1996

Hoechst synthesizes NOS inhibitors

June 21, 1996

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

Alzheimer's beta-protein inhibition method described

June 21, 1996

Cholinergic agonists claimed by Lilly

June 21, 1996

Agents for multiple sclerosis disclosed

June 21, 1996

Peptides resembling h-MBP claimed

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...